MedPath

Evaluation of the effect of herbal food product in patients with COVID 19

Phase 3
Conditions
COVID-19.
COVID-19, virus identified
U07.1
Registration Number
IRCT20150815023620N9
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
150
Inclusion Criteria

confirmed COVID-19 infection with Lab tests not considering sign and symptoms
suspected COVID-19 infection based on national protocol include the patients who has respiratory signs and pulmonary unilateral or bilateral multilobar infiltration in CT scan or chest radiography
suspected patient to pneumonia with uncommon rapid deterioration and fast worsening of clinical status and not responding to proper treatments
age 30 to 65

Exclusion Criteria

late visit more than 5 days of onset of symptoms
pregnancy and breastfeeding
alergy history
complicated bacterial infection
severe and critical patients ( ARDS and MODS )
patient in recovery phase

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Death. Timepoint: daily. Method of measurement: Patient record.;Fever (temperature ). Timepoint: Daily. Method of measurement: Thermometer.;SPO2. Timepoint: Daily. Method of measurement: Pulse oximetry.;CRP. Timepoint: Daily. Method of measurement: Biochemical testing.;ESR. Timepoint: Daily. Method of measurement: ESR Reader.;LDH. Timepoint: Daily. Method of measurement: Biochemical testing.;SGPT. Timepoint: Daily. Method of measurement: Biochemical testing.;SGOT. Timepoint: Daily. Method of measurement: Biochemical testing.;BUN. Timepoint: Daily. Method of measurement: Biochemical testing.;Cr. Timepoint: Daily. Method of measurement: Biochemical testing.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath